• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Florida bill advances

Article

Last week, the Florida Senate voted 10-3 to approve SB 278, a bill which would grant additional prescribing authority to optometrists.

 

Tallahassee, FL-Last week, the Florida Senate voted 10-3 to approve SB 278, a bill which would grant additional prescribing authority to optometrists.

The bill grants optometrists the ability to prescribe oral medications. The language of SB 278 states: “requiring a certified optometrist to complete a course and examination on general and ocular pharmaceutical agents before administering or prescribing oral ocular pharmaceutical agents.”

The bill has moved to the Appropriations Committee.

A similar bill, HB 239,  is in the Florida House Health & Human Services Committee. 

Related Videos
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.